-
公开(公告)号:US20170130255A1
公开(公告)日:2017-05-11
申请号:US15356132
申请日:2016-11-18
Applicant: ModernaTX, Inc.
Inventor: Yuxun Wang , Divakar Ramakrishnan , Antonin De Fougerolles , Susan Whoriskey
CPC classification number: C12P19/34 , C12N9/1241 , C12N9/1247 , C12N9/1252 , C12Y207/07006 , C12Y207/07007 , C12Y207/0705
Abstract: The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.
-
公开(公告)号:US09512456B2
公开(公告)日:2016-12-06
申请号:US14421291
申请日:2013-08-13
Applicant: ModernaTX, Inc.
Inventor: Yuxun Wang , Divakar Ramakrishnan , Antonin de Fougerolles , Susan Whoriskey
CPC classification number: C12P19/34 , C12N9/1241 , C12N9/1247 , C12N9/1252 , C12Y207/07006 , C12Y207/07007 , C12Y207/0705
Abstract: The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.
Abstract translation: 本发明涉及用于与多核苷酸,初级转录物和mmRNA分子一起使用的酶的设计,进化,制备和/或制备的组合物和方法。
-
3.
公开(公告)号:US10258698B2
公开(公告)日:2019-04-16
申请号:US14775773
申请日:2014-03-14
Applicant: ModernaTX, Inc.
Inventor: Stephen G. Hoge , Örn Almarsson , David D. Hile , Ciarán Lawlor , John Podobinski , Staci Sabnis , Antonin de Fougerolles , Divakar Ramakrishnan , Kristy M. Wood
Abstract: The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity.
-
公开(公告)号:US09790531B2
公开(公告)日:2017-10-17
申请号:US15356132
申请日:2016-11-18
Applicant: ModernaTX, Inc.
Inventor: Yuxun Wang , Divakar Ramakrishnan , Antonin De Fougerolles , Susan Whoriskey
CPC classification number: C12P19/34 , C12N9/1241 , C12N9/1247 , C12N9/1252 , C12Y207/07006 , C12Y207/07007 , C12Y207/0705
Abstract: The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.
-
5.
公开(公告)号:US20190142971A1
公开(公告)日:2019-05-16
申请号:US16050845
申请日:2018-07-31
Applicant: ModernaTX, Inc.
Inventor: Stephen G. Hoge , Örn Almarsson , David D. Hile , Ciáran Lawlor , John Podobinski , Staci Sabnis , Antonin De Fougerolles , Divakar Ramakrishnan , Kristy M. Wood
Abstract: The present disclosure provides, inter alia, formulation compositions comprising modified nucleic acid molecules which may encode a protein, a protein precursor, or a partially or fully processed form of the protein or a protein precursor. The formulation composition may further include a modified nucleic acid molecule and a delivery agent. The present invention further provides nucleic acids useful for encoding polypeptides capable of modulating a cell's function and/or activity.
-
-
-
-